ConductScience.org, home

Gene · 4014

Papers2,126

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Anoectochilus roxburghii extract alleviates inflammation and restores skin barrier function in vitro and in vivo.Fitoterapia202642800590PubTator, text miningPubMed
ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars.Int J Mol Sci202642794700PubTator, text miningPubMed
Lipoic acid synthase modulates psoriasis-like keratinocyte dysfunction in association with oxidative stress, ferroptosis-associated remodeling, and STAT3/NF-κB activation.Naunyn Schmiedebergs Arch Pharmacol202642776206PubTator, text miningPubMed
Characterization of epidermal and dermal remodeling following skin injury by sulfur mustard in Göttingen minipigs.Cutan Ocul Toxicol202642632083PubTator, text miningPubMed
Comparative analysis of candidate gene expression in Asian atopic dermatitis and psoriasis: identification of shared and distinct molecular features.Front Med (Lausanne)202642614128PubTator, text miningPubMed
Multi-omics integration of gut-skin axis in probiotic-treated dermatological conditions.Front Cell Infect Microbiol202642516436PubTator, text miningPubMed
Translational Assessment of a Cell-Penetrating Peptide Topical Formulation for Repairing Barrier Dysfunction in Human Skin.Int J Mol Sci202642511700PubTator, text miningPubMed
Jaungo-based herbal complex regulates psoriasis-associated macrophage-keratinocyte inflammatory axis.Front Pharmacol202642482777PubTator, text miningPubMed
Interface-engineered supramolecular collagen peptide nanocapsules for barrier repair and matrix remodeling: From molecular assembly to clinical translation.J Control Release202642480655PubTator, text miningPubMed
The LCE3D/TGF-β1 Axis in atopic dermatitis: Expression profiling, clinical significance, and mechanistic insights into epithelial-immune crosstalk.Clin Immunol202642435926PubTator, text miningPubMed
Plant oil complex: dual activation of peroxisome proliferator-activated receptors α and γ to enhance skin barrier function.Open Life Sci202642415821PubTator, text miningPubMed
Utility of Combined Immunohistochemical Staining for AMBRA1 and Loricrin for Improving the Pathologic Diagnosis of High-Grade Dysplastic Nevi.Am J Dermatopathol202642358006PubTator, text miningPubMed
High-Level Secretory Expression of Recombinant Type XVII Human-like Collagen in Komagataella phaffii.Int J Mol Sci202642353332PubTator, text miningPubMed
Dual targeting of cutaneous inflammation and vasculopathy via STING-NF-κB blockade underlies the anti-psoriatic efficacy of Yinxie Granules.Chin J Nat Med202642285688PubTator, text miningPubMed
Ultrasound-assisted enzymatic extraction of citrus pomace yields dietary fiber-rich extract with skin-protective effects.J Sci Food Agric202642240571PubTator, text miningPubMed
Protective effects of Passiflora edulis Sims peel fermentation polysaccharide against UVB-induced photodamage via antioxidant and anti-inflammatory activities.Bioresour Bioprocess202642234232PubTator, text miningPubMed
Immunological and molecular biomarkers in skin allergy therapy: monitoring inflammation, barrier function, and treatment response.Postepy Dermatol Alergol202642222448PubTator, text miningPubMed
Neonatal urinary phthalate metabolite concentrations are associated with the development of atopic dermatitis.Ann Allergy Asthma Immunol202642217752PubTator, text miningPubMed
High-level secretory production of a highly hydrophilic human-like type III collagen in Komagataella phaffii by a multicopy genomic integration strategy.Biotechnol Lett202642217068PubTator, text miningPubMed
Loss-of-function variants in EPHX3 cause nonsyndromic epidermal differentiation disorders.Br J Dermatol202642178907PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4014/papers